最新报道:According to Bijie.com, on September 20 (UTC+8), Faraday Future (NASDAQ: FFAI) announced today that it will make a strategic investment in Qualigen Therapeutics (NASDAQ: QLGN) through a $41 million PIPE transaction. Qualigen Therapeutics will be renamed CXC10 and transformed into a crypto and Web3 business platform. The strong investor lineup includes Faraday Future and Jia Yueting personally, as well as SIGN Foundation, a blockchain technology company backed by YZI Labs, Sequoia Capital (US, India, and China), IDG, and Circle.